Table 7 Comparison of curative effects between mild fibrosis subgroup and moderate-severe fibrosis subgroup.

From: Evaluation of the efficacy of Biejia decoction pill combined with entecavir in the treatment of hepatitis B liver fibrosis/cirrhosis by VCTE

Degree of liver fibrosis

Before treatment LSM/kPa

After treatment LSM/kPa

Effective treatment*, n (n%)

Mild

Control group (44)

8.3 (7.625, 8.9)

7.05 (6.6, 7.3)

31 (70.45%)

Observation group (47)

8.5 (7.9, 9)

5.8 (5.2, 6.9)

36 (76.6%)

χ2

NA

NA

0.441

P

0.3996

 < 0.0001

0.506

Moderate–severe

Control group (41)

11.7 (10.6, 13.35)

9.3 (8. 1,10.75)

6 (14.63%)

Observation group (39)

12.3 (10.5, 13.8)

8.1 (6.8,9.4)

14 (35.9%)

χ2

NA

NA

4.82

P

0.554

0.0038

0.028

  1. *Effective treatment: VCTE detection value < 7.3 kPa after treatment.